Evommune (EVMN) Shares Outstanding (2024 - 2026)

Evommune (EVMN) has reported Shares Outstanding (Entity) for 3 consecutive years, with $36.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 2219.45% year-over-year to $36.0 million; the TTM figure through Mar 2026 stood at $36.0 million (up 2219.45% YoY), while the FY2025 annual figure was $6.1 million, up 295.55% from the prior year.
• Shares Outstanding (Entity) grew to $36.0 million in Q1 2026 per EVMN's latest filing, from $6.1 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $36.0 million in Q1 2026 and bottomed at $1.5 million in Q3 2024.
• Historically, Shares Outstanding (Entity) has averaged $8.1 million across 3 years, with a median of $1.6 million in 2025.
• Annual changes were most pronounced in 2025 — Shares Outstanding (Entity) grew 0.59% — and 2026, when it surged 2219.45%.
• Evommune's Shares Outstanding (Entity) stood at $1.6 million in 2024, then jumped by 295.55% to $6.1 million in 2025, then soared by 486.94% to $36.0 million in 2026.
• Business Quant data shows EVMN's Shares Outstanding (Entity) at $36.0 million in Q1 2026, $6.1 million in Q4 2025, and $1.6 million in Q3 2025.